582 Companies
Halozyme Therapeutics Inc., a biopharmaceutical technology platform company that focuses on the research, development and commercialization of proprietary enzymes and devices, operates in the Unite...
Halozyme Therapeutics Annual Report 2023MeiraGTx Holdings plc, a New York-based clinical stage gene therapy company, is making significant strides in developing treatments for patients suffering from severe diseases. With a focus on addr...
MeiraGTx Annual Report 2023Biotech firm Vaxart, Inc. is dedicated to developing and discovering oral recombinant protein vaccines using its proprietary technology. One of the company's current products in the pipeline is an ...
Vaxart Annual Report 2023South San Francisco-based clinical-stage biopharmaceutical firm Catalyst Biosciences, Inc. is ramping up its efforts to develop and market innovative treatments targeting liver fibrosis associated ...
Catalyst Biosciences, Inc. Annual Report 2021Lexicon Pharmaceuticals is a biopharmaceutical company that specializes in the discovery and development of potential drug candidates for various human diseases. The company is committed to develop...
Lexicon Pharmaceuticals Inc Annual Report 2023Selecta Biosciences, a clinical-stage biopharmaceutical company, is making waves in the medical field with their research and development of nanoparticle immunomodulatory drugs. These drugs have th...
Selecta Biosciences Annual Report 2021AC Immune SA, a Swiss clinical-stage biopharmaceutical company, has been making waves with its innovative approach to preventing and treating neurodegenerative diseases. Boasting an impressive port...
AC Immune Annual Report 2023Exelixis, a biotech firm specializing in oncology, is dedicated to discovering, developing and marketing new cancer treatments in the U.S. The company offers CABOMETYX tablets for patients with adv...
Exelixis Annual Report 2023Biopharmaceutical company, CytomX Therapeutics Inc., is making strides in cancer treatment with their antibody therapeutics based on their Probody technology platform. The company's impressive prod...
CytomX Therapeutics Annual Report 2023Clovis Oncology is a biopharmaceutical company that specializes in developing anti-cancer agents for patients in the United States, Europe, and other parts of the world. The company is currently fo...
Clovis Oncology Annual Report 2020Sunesis is a biopharmaceutical company that is currently in the clinical stage of development. The company's main goal is to discover, develop, and ultimately commercialize new small molecule thera...
Sunesis Pharmaceuticals, Inc. Annual Report 2021ImmunoGen, a Waltham-based biotechnology company, has made significant advances in developing antibody-drug conjugates (ADCs) for cancer patients. Its portfolio includes mirvetuximab soravtansine, ...
ImmunoGen Annual Report 20214D Pharma PLC is a top company in the development of Live Biotherapeutics, a new class of drugs that includes live organisms to prevent, treat, or cure diseases. The company boasts a state-of-the-a...
4D Pharma PLC Annual Report 2020Interpace Biosciences, Inc.: Combining Molecular Diagnostics, Bioinformatics, and Pathology Services to Revolutionize Cancer Risk Evaluation in the United States Interpace Biosciences, Inc. has be...
Interpace Biosciences, Inc. Annual Report 2023Fusion Antibodies Plc is a company focused on discovering antibodies that can help revolutionize the healthcare industry. The company provides a comprehensive range of services related to antibodie...
Fusion Antibodies Plc Annual Report 2023